Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;22(2):269-275.
doi: 10.1007/s10238-021-00749-1. Epub 2021 Aug 4.

Cirrhosis regression after SVR with indirect methods of fibrosis analysis: How far is it real?

Walnei Fernandes Barbosa  1 , Vanessa Gutierrez Andrade  1 , Aline Márcia Marques Braz  1 , Fernanda Cristina Winckler  1 , Livia Roma Barbosa  2 , Márjorie de Assis Golim  3 , Liciana Vaz de Arruda Silveira  4 , Rafael Plana Simões  3   5 , Giovanni Faria Silva  6   7
Affiliations

Cirrhosis regression after SVR with indirect methods of fibrosis analysis: How far is it real?

Walnei Fernandes Barbosa et al. Clin Exp Med. 2022 May.

Abstract

Hepatitis C virus has infected over 71 million people worldwide, and it is the main cause of cirrhosis in the western world. Currently, the treatment involves direct-acting antiviral agents (DAAs) and its main goal is to achieve sustained virologic response (SVR). The aim of this study was to evaluate the impact of SVR using DAAs in the improvement of liver fibrosis using scores evaluation by indirect method, liver function, and inflammation indirect biomarkers. Patients with cirrhosis with SVR after treatment (n = 104) were evaluated using liver function scores, indirect fibrosis methods, alpha-fetoprotein, and ferritin at t-base and t-SVR. Statistically significant positive results in all parameters were observed: 54 patients were classified as 5 in the CP score in t-base, and 77 in t-SVR; a significant decrease was observed in MELD score, alpha-fetoprotein, ferritin, APRI, FIB-4 and liver stiffness in liver elastography. We did not observe difference in the liver function scores between regressors and non-regressors of liver stiffness, as well as in indirect inflammation biomarkers. The measurements of fibrosis using the indirect methods have significantly decreased in patients with cirrhosis treated who achieved SVR associated with decreased indirect inflammation biomarkers and improved liver function scores.

Keywords: Cirrhosis; DAAs; Fibrosis regression; HCV; Stiffness.

PubMed Disclaimer

References

    1. Hepatitis C. World Health Organization; 2018. http://www.who.int/news-room/fact-sheets/detail/hepatitis-c
    1. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding-unresolved issues. SumMary of an American association for the study of liver diseases and European association for the study of the liver single-topic conference. Hepatology. 2008;47:1764–72. https://doi.org/10.1002/hep.22273 . - DOI - PubMed
    1. Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32:1407–14. https://doi.org/10.1111/j.1478-3231.2012.02830.x . - DOI - PubMed - PMC
    1. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69: 406–460. doi.org/ https://doi.org/10.1016/j.jhep.2018.03.024
    1. D’Amico G, Morabito A, D’Amico M, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68:563–76. https://doi.org/10.1016/j.jhep.2017.10.020 . - DOI - PubMed

LinkOut - more resources